SuPine Therapeutics Inc., a UNIST-based biotech enterprise based by Professor Jeong Beom Kim within the Division of Life Sciences at UNIST has just lately been honored with the commendation from the Ministry of SMEs and Startups (MSS) on the 2022 Ulsan Startup Festa, which befell on November 30, 2022.
The award was straight associated to his latest analysis and improvement efforts to find potential cures for the sufferers with spinal cord injury (SCI), and thus contributing to the improvement of Korean society by means of the institution of SuPine Therapeutics Inc.
Beginning with the screening of the opening video beneath the theme of “Engraving the Spirit of Entrepreneurs,” the occasion was held within the following orders of the opening efficiency, awarding of commendations, in addition to a tour of the exhibition corridor. On the award presentation ceremony, Professor Jeong Beom Kim, founding father of SuPine Therapeutics Inc., acquired the commendation from the Ministry of SMEs and Startups, whereas President Min-Ki Kim of Cheongmyeong Superior Supplies Co., Ltd.) was given the commendation for startup benefit.
A brand new spinal-cord remedy developed by SuPine Therapeutics Inc. has proven wonderful therapeutic results in animal fashions of SCI, is pushing for good manufacturing follow (GMP) to carry out medical trials, and is actively finishing up licensing procedures to acquire approval from the Ministry of Food and Drug Security (MFDS) and the U.S. Food and Drug Administration (FDA).
“I’m deeply honored to obtain this prestigious award,” stated Professor Kim. “Particular because of UNIST and everybody who supported me from the second I began my very own enterprise.” He provides, “We are going to do our utmost to translate analysis findings into real-world medical follow.”
Disclaimer: AAAS and EurekAlert! aren’t liable for the accuracy of stories releases posted to EurekAlert! by contributing establishments or for the usage of any data by means of the EurekAlert system.